Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Brian Curran Healy, Ph.D.

Title
Institution
Department
Address
Other Positions
Title
Institution
Department

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Barro C, Healy BC, Saxena S, Glanz BI, Paul A, Polgar-Turcsanyi M, Guttmann CR, Bakshi R, Weiner HL, Chitnis T. Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients. Mult Scler. 2022 Nov 30; 13524585221137697. PMID: 36448331.
    Citations:    Fields:    
  2. Chitnis T, Kaskow BJ, Case J, Hanus K, Li Z, Varghese JF, Healy BC, Gauthier C, Saraceno TJ, Saxena S, Lokhande H, Moreira TG, Zurawski J, Roditi RE, Bergmark RW, Giovannoni F, Torti MF, Li Z, Quintana F, Clementi WA, Shailubhai K, Weiner HL, Baecher-Allan CM. Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects. Front Immunol. 2022; 13:956907. PMID: 36505477; PMCID: PMC9727230.
    Citations:    Fields:    Translation:HumansCells
  3. Barro C, Healy BC, Liu Y, Saxena S, Paul A, Polgar-Turcsanyi M, Guttmann CRG, Bakshi R, Kropshofer H, Weiner HL, Chitnis T. Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2023 01; 10(1). PMID: 36376097; PMCID: PMC9749933.
    Citations:    Fields:    Translation:Humans
  4. Feig EH, Harnedy LE, Thorndike AN, Psaros C, Healy BC, Huffman JC. A Positive Emotion-Focused Intervention to Increase Physical Activity After Bariatric Surgery: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2022 Oct 06; 11(10):e39856. PMID: 36201380; PMCID: PMC9585441.
    Citations:    
  5. Pol-Patil J, Glanz B, Safar L, Misasi E, Manieri MC, Shanahan R, Healy B, Houtchens M. MeTooMS: Sexual, physical, and emotional abuse experience among women with multiple sclerosis. Mult Scler. 2022 Sep 24; 13524585221122169. PMID: 36154526.
    Citations:    Fields:    
  6. Jessop ZM, Gibson J, Lim JY, Jovic TH, Combellack E, Dobbs TD, Carter K, Hiles S, Islam S, Healy B, Humphreys I, Eccles R, Hutchings HA, Whitaker IS. A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis-ICE-COVID. Trials. 2022 Sep 15; 23(1):782. PMID: 36109791; PMCID: PMC9477161.
    Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
  7. Bose G, Healy BC, Barro C, Glanz BI, Lokhande HA, Polgar-Turcsanyi M, Guttmann CR, Bakshi R, Weiner HL, Chitnis T. Younger age at multiple sclerosis onset is associated with worse outcomes at age 50. J Neurol Neurosurg Psychiatry. 2022 Aug 11. PMID: 35953266.
    Citations:    Fields:    
  8. Millstein RA, Golden J, Healy BC, Amonoo HL, Harnedy LE, Carrillo A, Celano CM, Huffman JC. Latent growth curve modeling of physical activity trajectories in a positive-psychology and motivational interviewing intervention for people with type 2 diabetes. Health Psychol Behav Med. 2022; 10(1):713-730. PMID: 35957957.
    Citations:    
  9. Holroyd KB, Healy BC, Conway S, Houtchens M, Bakshi R, Bhattacharyya S, Bose G, Galetta K, Kaplan T, Severson C, Singhal T, Stazzone L, Zurawski J, Polgar-Turcsanyi M, Saxena S, Paul A, Glanz BI, Weiner HL, Chitnis T. Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes. Mult Scler Relat Disord. 2022 Nov; 67:104079. PMID: 35952457; PMCID: PMC9330583.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  10. Sattarnezhad N, Healy BC, Baharnoori M, Diaz-Cruz C, Stankiewicz J, Weiner HL, Chitnis T. Comparison of dimethyl fumarate and interferon outcomes in an MS cohort. BMC Neurol. 2022 Jul 11; 22(1):252. PMID: 35820822; PMCID: PMC9277810.
    Citations:    Fields:    Translation:Humans
  11. Healy BC, Casady EC, Chitnis T, Weiner HL, Glanz BI. Estimating the association between physical activity and health-related quality of life in individuals with multiple sclerosis. Mult Scler Relat Disord. 2022 Sep; 65:104006. PMID: 35816952.
    Citations:    Fields:    
  12. Ostrem BL, Anderson A, Conway S, Healy BC, Oh J, Jacobs D, Dobson R, Graham EL, Sadovnick AD, Zimmerman V, Liu Y, Bove R, Houtchens M. Peripartum disease activity in moderately and severely disabled women with multiple sclerosis. Mult Scler J Exp Transl Clin. 2022 Apr-Jun; 8(2):20552173221104918. PMID: 35734229; PMCID: PMC9208060.
    Citations:    
  13. Conway SE, Healy BC, Zurawski J, Severson C, Kaplan T, Stazzone L, Galetta K, Chitnis T, Houtchens MK. COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders. Mult Scler Relat Disord. 2022 Jul; 63:103946. PMID: 35709663; PMCID: PMC9556032.
    Citations:    Fields:    Translation:Humans
  14. Fujiwara M, Raheja R, Garo LP, Ajay AK, Kadowaki-Saga R, Karandikar SH, Gabriely G, Krishnan R, Beynon V, Paul A, Patel A, Saxena S, Hu D, Healy BC, Chitnis T, Gandhi R, Weiner HL, Murugaiyan G. microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance. J Clin Invest. 2022 05 16; 132(10). PMID: 35298438; PMCID: PMC9106347.
    Citations:    Fields:    Translation:HumansAnimalsCells
  15. Bose G, Healy BC, Lokhande HA, Sotiropoulos MG, Polgar-Turcsanyi M, Anderson M, Glanz BI, Guttman CRG, Bakshi R, Weiner HL, Chitnis T. Early Predictors of Clinical and MRI Outcomes Using Least Absolute Shrinkage and Selection Operator (LASSO) in Multiple Sclerosis. Ann Neurol. 2022 07; 92(1):87-96. PMID: 35429009.
    Citations:    Fields:    Translation:Humans
  16. North CM, Barczak A, Goldstein RH, Healy BC, Finkelstein DM, Ding DD, Kim A, Boucau J, Shaw B, Gilbert RF, Vyas T, Reynolds Z, Siddle KJ, MacInnis BL, Regan J, Flynn JP, Choudhary MC, Vyas JM, Laskowski K, Dighe AS, Lemieux JE, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA. Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination. Clin Infect Dis. 2022 04 09; 74(7):1275-1278. PMID: 34363462; PMCID: PMC8436402.
    Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
  17. Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022 01 21; 375(6578):296-301. PMID: 35025605.
    Citations: 82     Fields:    Translation:HumansCells
  18. Lokhande H, Rosso M, Tauhid S, Chu R, Healy BC, Saxena S, Barro C, Paul A, Polgar-Turcsanyi M, Anderson M, Glanz BI, Kropshofer H, Granziera C, Leppert D, Kappos L, Kuhle J, Weiner HL, Bakshi R, Chitnis T. Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS. Mult Scler J Exp Transl Clin. 2022 Jan-Mar; 8(1):20552173211069348. PMID: 35035990; PMCID: PMC8753083.
    Citations: 1     
  19. Manglani HR, Healy BC, Vranceanu AM. Demand with low supply: A pipeline for personalized integrative medicine in multiple sclerosis. Mult Scler Relat Disord. 2022 Feb; 58:103493. PMID: 35030367.
    Citations:    Fields:    Translation:Humans
  20. Celano CM, Massey C, Long J, Kim S, Velasquez O, Healy BC, Wexler DJ, Madva EN, Huffman JC. An Adaptive, Algorithm-based Text Message Intervention to Promote Health Behavior Adherence in Type 2 Diabetes: Treatment Development and Proof-of-Concept Trial. J Diabetes Sci Technol. 2021 Dec 15; 19322968211065067. PMID: 34911398.
    Citations:    Fields:    
  21. Healy BC, Zurawski J, Chitnis T, Weiner HL, Glanz BI. Patient-reported outcomes associated with transition to secondary progressive multiple sclerosis. Qual Life Res. 2022 Jun; 31(6):1799-1805. PMID: 34783972.
    Citations:    Fields:    Translation:Humans
  22. Gabriely G, Ma D, Siddiqui S, Sun L, Skillin NP, Abou-El-Hassan H, Moreira TG, Donnelly D, da Cunha AP, Fujiwara M, Walton LR, Patel A, Krishnan R, Levine SS, Healy BC, Rezende RM, Murugaiyan G, Weiner HL. Myeloid cell subsets that express latency-associated peptide promote cancer growth by modulating T cells. iScience. 2021 Nov 19; 24(11):103347. PMID: 34820606; PMCID: PMC8602030.
    Citations:    
  23. Baharnoori M, Wilson R, Saxena S, Gonzalez CT, Sotiropoulos MG, Keyhanian K, Healy BC, Chitnis T. Altered adipokine levels are associated with dimethyl fumarate treatment in multiple sclerosis patients. Mult Scler Relat Disord. 2021 Nov; 56:103311. PMID: 34655958.
    Citations:    Fields:    Translation:Humans
  24. Solomon JM, Bhattacharyya S, Ali AS, Cleary L, Dibari S, Boxer R, Healy BC, Milligan TA. Randomized Study of Bedside vs Hallway Rounding: Neurology Rounding Study. Neurology. 2021 08 31; 97(9):434-442. PMID: 34158383.
    Citations:    Fields:    Translation:Humans
  25. Sotiropoulos MG, Lokhande H, Healy BC, Polgar-Turcsanyi M, Glanz BI, Bakshi R, Weiner HL, Chitnis T. Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability. Mult Scler J Exp Transl Clin. 2021 Apr-Jun; 7(2):20552173211015503. PMID: 34104471; PMCID: PMC8165535.
    Citations: 1     
  26. Glanz BI, Zurawski J, Casady EC, Shamah R, Weiner M, Chitnis T, Weiner HL, Healy BC. The impact of ocrelizumab on health-related quality of life in individuals with multiple sclerosis. Mult Scler J Exp Transl Clin. 2021 Apr-Jun; 7(2):20552173211007523. PMID: 34046184; PMCID: PMC8138295.
    Citations: 1     
  27. Cox LM, Maghzi AH, Liu S, Tankou SK, Dhang FH, Willocq V, Song A, Wasén C, Tauhid S, Chu R, Anderson MC, De Jager PL, Polgar-Turcsanyi M, Healy BC, Glanz BI, Bakshi R, Chitnis T, Weiner HL. Gut Microbiome in Progressive Multiple Sclerosis. Ann Neurol. 2021 06; 89(6):1195-1211. PMID: 33876477; PMCID: PMC8132291.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  28. Moreira Ferreira VF, Liu Y, Healy BC, Stankiewicz JM. Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis. Mult Scler J Exp Transl Clin. 2021 Apr-Jun; 7(2):20552173211010832. PMID: 33996142; PMCID: PMC8108088.
    Citations:    
  29. Amonoo HL, El-Jawahri A, Celano CM, Brown LA, Harnedy LE, Longley RM, Onyeaka HK, Healy BC, Cutler CS, Pirl WF, Lee SJ, Huffman JC. A positive psychology intervention to promote health outcomes in hematopoietic stem cell transplantation: the PATH proof-of-concept trial. Bone Marrow Transplant. 2021 09; 56(9):2276-2279. PMID: 33879852.
    Citations: 3     Fields:    Translation:Humans
  30. Healy BC, Glanz BI, Swallow E, Signorovitch J, Hagan K, Silva D, Pelletier C, Chitnis T, Weiner H. Confirmed disability progression provides limited predictive information regarding future disease progression in multiple sclerosis. Mult Scler J Exp Transl Clin. 2021 Apr-Jun; 7(2):2055217321999070. PMID: 33953937; PMCID: PMC8042549.
    Citations:    
  31. Chu DT, Rosso M, Gonzalez CT, Saxena S, Healy BC, Weiner HL, Chitnis T. Obesity is associated with the Optic Neuritis severity in Male patients with Multiple Sclerosis. Mult Scler Relat Disord. 2021 Jun; 51:102910. PMID: 33799288.
    Citations:    Fields:    Translation:Humans
  32. Healy BC. Machine and deep learning in MS research are just powerful statistics - No. Mult Scler. 2021 04; 27(5):663-664. PMID: 33625302.
    Citations:    Fields:    Translation:Humans
  33. Galetta K, Deshpande C, Healy BC, Glanz B, Ziehn M, Saxena S, Paul A, Saleh F, Collins M, Gaitan-Walsh P, Castro-Mendoza P, Weiner HL, Chitnis T. Serum neurofilament levels and patient-reported outcomes in multiple sclerosis. Ann Clin Transl Neurol. 2021 03; 8(3):631-638. PMID: 33492760.
    Citations: 4     Fields:    Translation:Humans
  34. Rosso M, Healy BC, Saxena S, Paul A, Bjornevik K, Kuhle J, Benkert P, Leppert D, Guttmann C, Bakshi R, Weiner HL, Chitnis T. MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis. J Neuroimaging. 2021 03; 31(2):388-393. PMID: 33476489.
    Citations: 3     Fields:    Translation:Humans
  35. Celano CM, Golden J, Healy BC, Longley RM, Huffman JC. Predictors of completion and response to a psychological intervention to promote health behavior adherence in heart failure. Int J Psychiatry Med. 2022 01; 57(1):21-34. PMID: 33461359; PMCID: PMC8300859.
    Citations:    Fields:    Translation:Humans
  36. Nikrahan GR, Ashaghi L, Amonoo HL, Hemmat A, Massey CN, Healy BC, Huffman JC. ERRATUM: A randomized trial of an optimism training intervention in patients with heart disease. Gen Hosp Psychiatry. 2021 Mar-Apr; 69:133. PMID: 33446347.
    Citations:    Fields:    
  37. Stone JH, Horick NK, Healy BC. Tocilizumab in Covid-19. Reply. N Engl J Med. 2021 01 07; 384(1):87. PMID: 33356050.
    Citations: 3     Fields:    Translation:HumansCells
  38. Moreira Ferreira VF, Caefer D, Erlich-Malona N, Healy BC, Chitnis T, Stankiewicz JM. Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis. Mult Scler Int. 2020; 2020:5471987. PMID: 33381316; PMCID: PMC7759400.
    Citations:    
  39. Huffman JC, Golden J, Massey CN, Feig EH, Chung WJ, Millstein RA, Brown L, Gianangelo T, Healy BC, Wexler DJ, Park ER, Celano CM. A positive psychology-motivational interviewing program to promote physical activity in type 2 diabetes: The BEHOLD-16 pilot randomized trial. Gen Hosp Psychiatry. 2021 Jan-Feb; 68:65-73. PMID: 33338737.
    Citations: 4     Fields:    Translation:Humans
  40. Hu D, Tjon EC, Andersson KM, Molica GM, Pham MC, Healy B, Murugaiyan G, Pochet N, Kuchroo VK, Bokarewa MI, Weiner HL. Aberrant expression of USF2 in refractory rheumatoid arthritis and its regulation of proinflammatory cytokines in Th17 cells. Proc Natl Acad Sci U S A. 2020 12 01; 117(48):30639-30648. PMID: 33203678.
    Citations: 7     Fields:    Translation:HumansCells
  41. Celano CM, Freedman ME, Harnedy LE, Park ER, Januzzi JL, Healy BC, Huffman JC. Feasibility and preliminary efficacy of a positive psychology-based intervention to promote health behaviors in heart failure: The REACH for Health study. J Psychosom Res. 2020 12; 139:110285. PMID: 33160091.
    Citations: 2     Fields:    Translation:Humans
  42. Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, Woolley AE, Nikiforow S, Lin N, Sagar M, Schrager H, Huckins DS, Axelrod M, Pincus MD, Fleisher J, Sacks CA, Dougan M, North CM, Halvorsen YD, Thurber TK, Dagher Z, Scherer A, Wallwork RS, Kim AY, Schoenfeld S, Sen P, Neilan TG, Perugino CA, Unizony SH, Collier DS, Matza MA, Yinh JM, Bowman KA, Meyerowitz E, Zafar A, Drobni ZD, Bolster MB, Kohler M, D'Silva KM, Dau J, Lockwood MM, Cubbison C, Weber BN, Mansour MK. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020 12 10; 383(24):2333-2344. PMID: 33085857; PMCID: PMC7646626.
    Citations: 510     Fields:    Translation:Humans
  43. Onyeaka HK, Romero P, Healy BC, Celano CM. Age Differences in the Use of Health Information Technology Among Adults in the United States: An Analysis of the Health Information National Trends Survey. J Aging Health. 2021 01; 33(1-2):147-154. PMID: 33031007.
    Citations: 6     Fields:    Translation:Humans
  44. Ratajska A, Glanz BI, Chitnis T, Weiner HL, Healy BC. Social support in multiple sclerosis: Associations with quality of life, depression, and anxiety. J Psychosom Res. 2020 11; 138:110252. PMID: 32971435.
    Citations: 3     Fields:    Translation:Humans
  45. Zambrano J, Celano CM, Chung WJ, Massey CN, Feig EH, Millstein RA, Healy BC, Wexler DJ, Park ER, Golden J, Huffman JC. Exploring the feasibility and impact of positive psychology-motivational interviewing interventions to promote positive affect and physical activity in type 2 diabetes: design and methods from the BEHOLD-8 and BEHOLD-16 clinical trials. Health Psychol Behav Med. 2020; 8(1):398-422. PMID: 33763296; PMCID: PMC7986224.
    Citations: 2     
  46. Houtchens M, Bove R, Healy B, Houtchens S, Kaplan TB, Mahlanza T, Chitnis T, Bakshi R. MRI activity in MS and completed pregnancy: Data from a tertiary academic center. Neurol Neuroimmunol Neuroinflamm. 2020 11 05; 7(6). PMID: 32917773.
    Citations: 2     Fields:    Translation:Humans
  47. Huffman JC, Golden J, Massey CN, Feig EH, Chung WJ, Millstein RA, Brown L, Gianangelo T, Healy BC, Wexler DJ, Park ER, Celano CM. A Positive Psychology-Motivational Interviewing Intervention to Promote Positive Affect and Physical Activity in Type 2 Diabetes: The BEHOLD-8 Controlled Clinical Trial. Psychosom Med. 2020 09; 82(7):641-649. PMID: 32665479; PMCID: PMC7676457.
    Citations: 3     Fields:    Translation:Humans
  48. Freedman ME, Healy BC, Huffman JC, Chitnis T, Weiner HL, Glanz BI. An At-home Positive Psychology Intervention for Individuals with Multiple Sclerosis: A Phase 1 Randomized Controlled Trial. Int J MS Care. 2021 May-Jun; 23(3):128-134. PMID: 34177385; PMCID: PMC8218588.
    Citations: 1     
  49. Shinn AK, Cawkwell PB, Bolton K, Healy BC, Karmacharya R, Yip AG, Öngür D, Pinder-Amaker S. Return to College After a First Episode of Psychosis. Schizophr Bull Open. 2020 Jan; 1(1):sgaa041. PMID: 32984820; PMCID: PMC7503481.
    Citations: 1     
  50. Zhang T, Goodman M, Zhu F, Healy B, Carruthers R, Chitnis T, Weiner H, Cai T, De Jager P, Tremlett H, Xia Z. Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity. Neurol Neuroimmunol Neuroinflamm. 2020 11; 7(6). PMID: 32817202; PMCID: PMC7673286.
    Citations: 6     Fields:    Translation:Humans
  51. Molsberry S, Bjornevik K, Hughes KC, Healy B, Schwarzschild M, Ascherio A. Diet pattern and prodromal features of Parkinson disease. Neurology. 2020 10 13; 95(15):e2095-e2108. PMID: 32817391; PMCID: PMC7713746.
    Citations: 6     Fields:    Translation:Humans
  52. Smith DM, Huffman JC, Healy BC, Duque L, Celano CM. Response to Letter to the Editor: "Real-World Considerations for Applicability of Text Message Interventions for Promotion of Physical Activity". Am J Prev Med. 2020 08; 59(2):e93-e94. PMID: 32690206.
    Citations:    Fields:    
  53. Rosso M, Gonzalez CT, Healy BC, Saxena S, Paul A, Bjornevik K, Kuhle J, Benkert P, Leppert D, Guttmann C, Bakshi R, Weiner HL, Chitnis T. Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis. Ann Clin Transl Neurol. 2020 06; 7(6):945-955. PMID: 32452160.
    Citations: 10     Fields:    Translation:Humans
  54. Healy BC, Barker L, Bakshi R, Benedict RHB, Gonzalez CT, Chitnis T, Weiner HL, Glanz BI. Trajectories of Symbol Digit Modalities Test performance in individuals with multiple sclerosis. Mult Scler. 2021 04; 27(4):593-602. PMID: 32228283.
    Citations: 1     Fields:    Translation:Humans
  55. Zurawski J, Healy BC, Ratajska A, Barker L, Glanz BI, Houtchens M. Identification of a predominant cognitive phenotype in patients with multiple sclerosis. Eur J Neurol. 2020 06; 27(6):1083-1088. PMID: 32080929.
    Citations: 2     Fields:    Translation:Humans
  56. Dickerman BA, Ebot EM, Healy BC, Wilson KM, Eliassen AH, Ascherio A, Pernar CH, Zeleznik OA, Vander Heiden MG, Clish CB, Giovannucci E, Mucci LA. A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study. Metabolites. 2020 Mar 10; 10(3). PMID: 32164144; PMCID: PMC7142752.
    Citations: 5     
  57. Huffman JC, Millstein RA, Celano CM, Healy BC, Park ER, Collins LM. Developing a Psychological-Behavioral Intervention in Cardiac Patients Using the Multiphase Optimization Strategy: Lessons Learned From the Field. Ann Behav Med. 2020 02 21; 54(3):151-163. PMID: 31586194.
    Citations: 1     Fields:    Translation:Humans
  58. Bakshi R, Healy BC, Dupuy SL, Kirkish G, Khalid F, Gundel T, Asteggiano C, Yousuf F, Alexander A, Hauser SL, Weiner HL, Henry RG. Brain MRI Predicts Worsening Multiple Sclerosis Disability over 5 Years in the SUMMIT Study. J Neuroimaging. 2020 03; 30(2):212-218. PMID: 31994814.
    Citations: 1     Fields:    Translation:Humans
  59. Palotai M, Cavallari M, Healy BC, Guttmann CR. A novel classification of fatigue in multiple sclerosis based on longitudinal assessments. Mult Scler. 2020 05; 26(6):725-734. PMID: 31971067.
    Citations: 3     Fields:    Translation:Humans
  60. Glanz BI, Zurawski J, Gonzalez CT, Shamah R, Ratajska A, Chitnis T, Weiner HL, Healy BC. Comparison of health-related quality of life across treatment groups in individuals with multiple sclerosis. Mult Scler Relat Disord. 2020 May; 40:101944. PMID: 32007653.
    Citations: 1     Fields:    Translation:Humans
  61. Molsberry S, Bjornevik K, Hughes KC, Zhang ZJ, Jeanfavre S, Clish C, Healy B, Schwarzschild M, Ascherio A. Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease. J Parkinsons Dis. 2020; 10(3):1011-1021. PMID: 32250318.
    Citations: 1     Fields:    Translation:Humans
  62. Bjornevik K, Munger KL, Cortese M, Barro C, Healy BC, Niebuhr DW, Scher AI, Kuhle J, Ascherio A. Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis. JAMA Neurol. 2020 01 01; 77(1):58-64. PMID: 31515562; PMCID: PMC6745051.
    Citations: 42     Fields:    Translation:Humans
  63. Chitnis T, Glanz BI, Gonzalez C, Healy BC, Saraceno TJ, Sattarnezhad N, Diaz-Cruz C, Polgar-Turcsanyi M, Tummala S, Bakshi R, Bajaj VS, Ben-Shimol D, Bikhchandani N, Blocker AW, Burkart J, Cendrillon R, Cusack MP, Demiralp E, Jooste SK, Kharbouch A, Lee AA, Lehár J, Liu M, Mahadevan S, Murphy M, Norton LC, Parlikar TA, Pathak A, Shoeb A, Soderberg E, Stephens P, Stoertz AH, Thng F, Tumkur K, Wang H, Rhodes J, Rudick RA, Ransohoff RM, Phillips GA, Bruzik E, Marks WJ, Weiner HL, Snyder TM. Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis. NPJ Digit Med. 2019 Dec 11; 2(1):123. PMID: 33299125.
    Citations:    
  64. Varkaris A, Xu W, Davis RB, Healy B, McDermott DF. Combining Immune Checkpoint and VEGFR Inhibition in Favorable Risk and Elderly Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2020 06; 18(3):179-184.e3. PMID: 32144046; PMCID: PMC7875559.
    Citations: 2     Fields:    Translation:Humans
  65. Smith DM, Duque L, Huffman JC, Healy BC, Celano CM. Text Message Interventions for Physical Activity: A Systematic Review and Meta-Analysis. Am J Prev Med. 2020 01; 58(1):142-151. PMID: 31759805.
    Citations: 17     Fields:    Translation:Humans
  66. Zurawski J, Tauhid S, Chu R, Khalid F, Healy BC, Weiner HL, Bakshi R. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions. Mult Scler. 2020 02; 26(2):177-187. PMID: 31714181.
    Citations: 15     Fields:    Translation:Humans
  67. Palotai M, Nazeri A, Cavallari M, Healy BC, Glanz B, Gold SM, Weiner HL, Chitnis T, Guttmann CRG. History of fatigue in multiple sclerosis is associated with grey matter atrophy. Sci Rep. 2019 10 14; 9(1):14781. PMID: 31611598.
    Citations: 8     Fields:    Translation:Humans
  68. Keyhanian K, Saxena S, Gombolay G, Healy BC, Misra M, Chitnis T. Adipokines are associated with pediatric multiple sclerosis risk and course. Mult Scler Relat Disord. 2019 Nov; 36:101384. PMID: 31550559.
    Citations: 4     Fields:    Translation:Humans
  69. Palotai M, Cavallari M, Koubiyr I, Morales Pinzon A, Nazeri A, Healy BC, Glanz B, Weiner HL, Chitnis T, Guttmann CR. Microstructural fronto-striatal and temporo-insular alterations are associated with fatigue in patients with multiple sclerosis independent of white matter lesion load and depression. Mult Scler. 2020 11; 26(13):1708-1718. PMID: 31418637.
    Citations: 13     Fields:    Translation:Humans
  70. Yano H, Gonzalez C, Healy BC, Glanz BI, Weiner HL, Chitnis T. Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes. Mult Scler Relat Disord. 2019 Oct; 35:119-127. PMID: 31374460.
    Citations: 9     Fields:    Translation:Humans
  71. Nikrahan GR, Eshaghi L, Massey CN, Hemmat A, Amonoo HL, Healy B, Huffman JC. Randomized controlled trial of a well-being intervention in cardiac patients. Gen Hosp Psychiatry. 2019 Nov - Dec; 61:116-124. PMID: 31285062.
    Citations: 2     Fields:    Translation:Humans
  72. Duque L, Brown L, Celano CM, Healy B, Huffman JC. Is it better to cultivate positive affect or optimism? Predicting improvements in medical adherence following a positive psychology intervention in patients with acute coronary syndrome. Gen Hosp Psychiatry. 2019 Nov - Dec; 61:125-129. PMID: 31280918.
    Citations: 2     Fields:    Translation:Humans
  73. Barker L, Healy BC, Chan E, Leclaire K, Glanz BI. A Pilot Study to Assess At-Home Speed of Processing Training for Individuals with Multiple Sclerosis. Mult Scler Int. 2019; 2019:3584259. PMID: 31275652; PMCID: PMC6582794.
    Citations: 1     
  74. Ratajska A, Zurawski J, Healy B, Glanz BI. Computerized Cognitive Behavioral Therapy for Treatment of Depression in Multiple Sclerosis: A Narrative Review of Current Findings and Future Directions. Int J MS Care. 2019 May-Jun; 21(3):113-123. PMID: 31191176; PMCID: PMC6552991.
    Citations: 2     
  75. Zurawski J, Glanz BI, Healy BC, Tauhid S, Khalid F, Chitnis T, Weiner HL, Bakshi R. The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis. J Neurol Sci. 2019 Aug 15; 403:38-43. PMID: 31207364.
    Citations: 3     Fields:    Translation:Humans
  76. Huffman JC, Feig EH, Millstein RA, Freedman M, Healy BC, Chung WJ, Amonoo HL, Malloy L, Slawsby E, Januzzi JL, Celano CM. Usefulness of a Positive Psychology-Motivational Interviewing Intervention to Promote Positive Affect and Physical Activity After an Acute Coronary Syndrome. Am J Cardiol. 2019 06 15; 123(12):1906-1914. PMID: 30979409; PMCID: PMC6529259.
    Citations: 13     Fields:    Translation:Humans
  77. Rosso M, Kimbrough DJ, Gonzalez CT, Glanz BI, Healy BC, Rocca MA, Filippi M, Weiner H, Chitnis T. Cross-sectional study of smoking exposure: no differential effect on OCT metrics in a cohort of MS patients. Mult Scler J Exp Transl Clin. 2019 Jan-Mar; 5(1):2055217319828400. PMID: 30828461; PMCID: PMC6390224.
    Citations: 3     
  78. Hemond CC, Healy BC, Tauhid S, Mazzola MA, Quintana FJ, Gandhi R, Weiner HL, Bakshi R. MRI phenotypes in MS: Longitudinal changes and miRNA signatures. Neurol Neuroimmunol Neuroinflamm. 2019 03; 6(2):e530. PMID: 30800720.
    Citations: 12     Fields:    Translation:Humans
  79. Huffman JC, Legler S, Millstein RA, Gomez-Bernal F, Celano CM, Chung WJ, Healy BC. Does timeframe adjustment of the Life Orientation Test-Revised assess optimism as a state?: Data from the PEACE-III trial in patients with heart disease. J Posit Psychol. 2019; 14(6):799-806. PMID: 32983245; PMCID: PMC7518220.
    Citations:    
  80. Hemond CC, Glanz BI, Bakshi R, Chitnis T, Healy BC. The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis. BMC Neurol. 2019 Feb 12; 19(1):23. PMID: 30755165; PMCID: PMC6371437.
    Citations: 17     Fields:    Translation:HumansCells
  81. Zurawski J, Glanz BI, Chua A, Lokhande H, Rotstein D, Weiner H, Engler D, Chitnis T, Healy BC. Time between expanded disability status scale (EDSS) scores. Mult Scler Relat Disord. 2019 May; 30:98-103. PMID: 30763908.
    Citations: 3     Fields:    Translation:Humans
  82. Kaplan TB, Bove R, Galetta K, Healy B, Chitnis C, Houtchens M. Effect of pregnancy loss on MS disease activity. J Neurol Sci. 2019 Feb 15; 397:58-60. PMID: 30590343.
    Citations: 2     Fields:    Translation:Humans
  83. Fakih R, Diaz-Cruz C, Chua AS, Gonzalez C, Healy BC, Sattarnezhad N, Glanz BI, Weiner HL, Chitnis T. Food allergies are associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2019 06; 90(6):629-635. PMID: 30563943.
    Citations: 1     Fields:    Translation:Humans
  84. Raheja R, Regev K, Healy BC. Study of serum microrna expression in amyotrophic lateral sclerosis patients: The challenge of selecting suitable internal control for normalization. Muscle Nerve. 2019 01; 59(1):E3-E4. PMID: 30383297.
    Citations:    Fields:    Translation:Humans
  85. Chu R, Kim G, Tauhid S, Khalid F, Healy BC, Bakshi R. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines. PLoS One. 2018; 13(11):e0206939. PMID: 30408094.
    Citations: 5     Fields:    Translation:Humans
  86. Healy BC, Zurawski J, Gonzalez CT, Chitnis T, Weiner HL, Glanz BI. Assessment of computer adaptive testing version of the Neuro-QOL for people with multiple sclerosis. Mult Scler. 2019 11; 25(13):1791-1799. PMID: 30381985.
    Citations: 1     Fields:    Translation:Humans
  87. Chitnis T, Gonzalez C, Healy BC, Saxena S, Rosso M, Barro C, Michalak Z, Paul A, Kivisakk P, Diaz-Cruz C, Sattarnezhad N, Pierre IV, Glanz BI, Tomic D, Kropshofer H, Häring D, Leppert D, Kappos L, Bakshi R, Weiner HL, Kuhle J. Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis. Ann Clin Transl Neurol. 2018 Dec; 5(12):1478-1491. PMID: 30564615; PMCID: PMC6292183.
    Citations: 41     Fields:    
  88. Healy BC, Glanz BI, Zurawski JD, Mazzola M, Chitnis T, Weiner HL. Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta and glatiramer acetate. J Neurol Sci. 2018 11 15; 394:127-131. PMID: 30248571.
    Citations: 2     Fields:    Translation:Humans
  89. Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola MA, Raheja R, Glanz BI, Kivisäkk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, Khoury SJ, Weiner HL, Gandhi R. Identification of MS-specific serum miRNAs in an international multicenter study. Neurol Neuroimmunol Neuroinflamm. 2018 Sep; 5(5):e491. PMID: 30175165; PMCID: PMC6117192.
    Citations: 22     Fields:    
  90. Hemond CC, Chu R, Tummala S, Tauhid S, Healy BC, Bakshi R. Whole-brain atrophy assessed by proportional- versus registration-based pipelines from 3T MRI in multiple sclerosis. Brain Behav. 2018 08; 8(8):e01068. PMID: 30019857.
    Citations: 3     Fields:    Translation:Humans
  91. Dastagir A, Healy BC, Chua AS, Chitnis T, Weiner HL, Bakshi R, Tauhid S. Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis. eNeurologicalSci. 2018 Sep; 12:42-46. PMID: 30229136; PMCID: PMC6141305.
    Citations: 7     
  92. Celano CM, Albanese AM, Millstein RA, Mastromauro CA, Chung WJ, Campbell KA, Legler SR, Park ER, Healy BC, Collins LM, Januzzi JL, Huffman JC. Optimizing a Positive Psychology Intervention to Promote Health Behaviors After an Acute Coronary Syndrome: The Positive Emotions After Acute Coronary Events III (PEACE-III) Randomized Factorial Trial. Psychosom Med. 2018 Jul/Aug; 80(6):526-534. PMID: 29624523.
    Citations: 25     Fields:    Translation:Humans
  93. Khalid F, Healy BC, Dupuy SL, Chu R, Chitnis T, Bakshi R, Houtchens M. Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis. J Neurol Sci. 2018 09 15; 392:94-99. PMID: 30031994.
    Citations: 3     Fields:    Translation:Humans
  94. Campbell KA, Healy BC, Celano CM, Albanese A, Millstein RA, Huffman JC. Predictors of completion of a psychological-behavioral intervention in acute coronary syndrome patients. J Psychosom Res. 2018 09; 112:9-12. PMID: 30097141.
    Citations: 2     Fields:    Translation:Humans
  95. Tankou SK, Regev K, Healy BC, Tjon E, Laghi L, Cox LM, Kivisäkk P, Pierre IV, Hrishikesh L, Gandhi R, Cook S, Glanz B, Stankiewicz J, Weiner HL. A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol. 2018 06; 83(6):1147-1161. PMID: 29679417; PMCID: PMC6181139.
    Citations: 58     Fields:    Translation:HumansCells
  96. Leclaire K, Cecil A, LaRussa A, Stuart F, Hemond CC, Healy BC, Chitnis T, Weiner H, Huffman J, Glanz BI. Short Report: A Pilot Study of a Group Positive Psychology Intervention for Patients with Multiple Sclerosis. Int J MS Care. 2018 May-Jun; 20(3):136-141. PMID: 29896050; PMCID: PMC5991506.
    Citations: 6     
  97. Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, Von Glehn F, Paul A, Diaz-Cruz C, Gholipour T, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Berry JD, Gandhi R. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018 Aug; 58(2):261-269. PMID: 29466830.
    Citations: 39     Fields:    Translation:Humans
  98. Legler SR, Beale EE, Celano CM, Beach SR, Healy BC, Huffman JC. State Gratitude for One's Life and Health after an Acute Coronary Syndrome: Prospective Associations with Physical Activity, Medical Adherence and Re-hospitalizations. J Posit Psychol. 2019; 14(3):283-291. PMID: 31217805; PMCID: PMC6583888.
    Citations:    
  99. Tankou SK, Regev K, Healy BC, Cox LM, Tjon E, Kivisakk P, Vanande IP, Cook S, Gandhi R, Glanz B, Stankiewicz J, Weiner HL. Investigation of probiotics in multiple sclerosis. Mult Scler. 2018 01; 24(1):58-63. PMID: 29307299.
    Citations: 34     Fields:    Translation:HumansCellsCTClinical Trials
  100. Baharnoori M, Gonzalez CT, Chua A, Diaz-Cruz C, Healy BC, Stankiewicz J, Weiner HL, Chitnis T. Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count. Mult Scler Relat Disord. 2018 Feb; 20:51-57. PMID: 29304497.
    Citations: 6     Fields:    Translation:Humans
  101. Cavallari M, Egorova S, Healy BC, Palotai M, Prieto JC, Polgar-Turcsanyi M, Tauhid S, Anderson M, Glanz B, Chitnis T, Guttmann CRG. Evaluating the Association between Enlarged Perivascular Spaces and Disease Worsening in Multiple Sclerosis. J Neuroimaging. 2018 05; 28(3):273-277. PMID: 29226505.
    Citations: 12     Fields:    Translation:Humans
  102. Yousuf F, Dupuy SL, Tauhid S, Chu R, Kim G, Tummala S, Khalid F, Weiner HL, Chitnis T, Healy BC, Bakshi R. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis. J Neurol Sci. 2017 Dec 15; 383:221-229. PMID: 29146095.
    Citations: 3     Fields:    Translation:Humans
  103. Eagle T, Stuart F, Chua AS, LaRussa A, Leclaire K, Cook SL, Chitnis T, Weiner HL, Glanz BI, Healy BC. Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosis. Mult Scler Relat Disord. 2017 Nov; 18:196-201. PMID: 29141809.
    Citations: 5     Fields:    Translation:Humans
  104. Greeke EE, Chua AS, Healy BC, Rintell DJ, Chitnis T, Glanz BI. Depression and fatigue in patients with multiple sclerosis. J Neurol Sci. 2017 Sep 15; 380:236-241. PMID: 28870578.
    Citations: 11     Fields:    Translation:Humans
  105. Diaz-Cruz C, Chua AS, Malik MT, Kaplan T, Glanz BI, Egorova S, Guttmann CRG, Bakshi R, Weiner HL, Healy BC, Chitnis T. The effect of alcohol and red wine consumption on clinical and MRI outcomes in multiple sclerosis. Mult Scler Relat Disord. 2017 Oct; 17:47-53. PMID: 29055473.
    Citations: 11     Fields:    Translation:Humans
  106. Sattarnezhad N, Farrow S, Kimbrough D, Glanz B, Healy B, Chitnis T. Agreement analysis comparing iPad LCVA and Sloan testing in multiple sclerosis patients. Mult Scler. 2018 07; 24(8):1126-1130. PMID: 28585909.
    Citations: 2     Fields:    Translation:Humans
  107. Palotai M, Mike A, Cavallari M, Strammer E, Orsi G, Healy BC, Schregel K, Illes Z, Guttmann CR. Changes to the septo-fornical area might play a role in the pathogenesis of anxiety in multiple sclerosis. Mult Scler. 2018 07; 24(8):1105-1114. PMID: 28548605.
    Citations: 10     Fields:    Translation:Humans
  108. Tummala S, Singhal T, Oommen VV, Kim G, Khalid F, Healy BC, Bakshi R. Spinal Cord as an Adjunct to Brain Magnetic Resonance Imaging in Defining "No Evidence of Disease Activity" in Multiple Sclerosis. Int J MS Care. 2017 May-Jun; 19(3):158-164. PMID: 28603465; PMCID: PMC5460870.
    Citations: 2     
  109. Zhao Y, Healy BC, Rotstein D, Guttmann CR, Bakshi R, Weiner HL, Brodley CE, Chitnis T. Exploration of machine learning techniques in predicting multiple sclerosis disease course. PLoS One. 2017; 12(4):e0174866. PMID: 28379999.
    Citations: 37     Fields:    Translation:Humans
  110. Celano CM, Beale EE, Beach SR, Belcher AM, Suarez L, Motiwala SR, Gandhi PU, Gaggin H, Januzzi JL, Healy BC, Huffman JC. Associations Between Psychological Constructs and Cardiac Biomarkers After Acute Coronary Syndrome. Psychosom Med. 2017 Apr; 79(3):318-326. PMID: 27749683.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  111. Healy BC, Buckle GJ, Ali EN, Egorova S, Khalid F, Tauhid S, Glanz BI, Chitnis T, Guttmann CRG, Weiner HL, Bakshi R. Characterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis. J Neuroimaging. 2017 09; 27(5):481-485. PMID: 28261936.
    Citations: 11     Fields:    Translation:Humans
  112. Regev K, Healy BC, Khalid F, Paul A, Chu R, Tauhid S, Tummala S, Diaz-Cruz C, Raheja R, Mazzola MA, von Glehn F, Kivisakk P, Dupuy SL, Kim G, Chitnis T, Weiner HL, Gandhi R, Bakshi R. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity. JAMA Neurol. 2017 03 01; 74(3):275-285. PMID: 28114622; PMCID: PMC6014611.
    Citations: 23     Fields:    Translation:Humans
  113. Kim G, Chu R, Yousuf F, Tauhid S, Stazzone L, Houtchens MK, Stankiewicz JM, Severson C, Kimbrough D, Quintana FJ, Chitnis T, Weiner HL, Healy BC, Bakshi R. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. Int J Neurosci. 2017 Nov; 127(11):971-980. PMID: 28100092.
    Citations: 5     Fields:    Translation:Humans
  114. Bargiela D, Bianchi MT, Westover MB, Chibnik LB, Healy BC, De Jager PL, Xia Z. Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis. Neurology. 2017 Feb 14; 88(7):677-684. PMID: 28087821; PMCID: PMC5317380.
    Citations: 6     Fields:    Translation:Humans
  115. Huffman JC, Albanese AM, Campbell KA, Celano CM, Millstein RA, Mastromauro CA, Healy BC, Chung WJ, Januzzi JL, Collins LM, Park ER. The Positive Emotions after Acute Coronary Events behavioral health intervention: Design, rationale, and preliminary feasibility of a factorial design study. Clin Trials. 2017 Apr; 14(2):128-139. PMID: 28079394; PMCID: PMC5376225.
    Citations: 14     Fields:    Translation:Humans
  116. Dupuy SL, Khalid F, Healy BC, Bakshi S, Neema M, Tauhid S, Bakshi R. The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis. BMC Med Imaging. 2016 10 05; 16(1):56. PMID: 27716096.
    Citations: 5     Fields:    Translation:Humans
  117. Schwartz CE, Rapkin BD, Healy BC. Reserve and Reserve-building activities research: key challenges and future directions. BMC Neurosci. 2016 09 15; 17(1):62. PMID: 27633657.
    Citations: 15     Fields:    Translation:Humans
  118. Glanz BI, Greeke E, LaRussa A, Stuart F, Rintell DJ, Chitnis T, Healy BC. Risk attitudes and risk perceptions in individuals with multiple sclerosis. Mult Scler J Exp Transl Clin. 2016 Jan-Dec; 2:2055217316665406. PMID: 28607735; PMCID: PMC5453630.
    Citations: 3     
  119. Regev K, Paul A, Healy B, von Glenn F, Diaz-Cruz C, Gholipour T, Mazzola MA, Raheja R, Nejad P, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Gandhi R. Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2016 Oct; 3(5):e267. PMID: 27606352.
    Citations: 34     Fields:    
  120. Healy BC, Weinshenker BG. Does early (treatment in) BENEFIT lead to late MS benefit? Neurology. 2016 09 06; 87(10):970-1. PMID: 27511185.
    Citations:    Fields:    Translation:Humans
  121. Yousuf F, Kim G, Tauhid S, Glanz BI, Chu R, Tummala S, Healy BC, Bakshi R. The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis. Front Neurol. 2016; 7:99. PMID: 27445966; PMCID: PMC4925661.
    Citations: 1     
  122. Bove R, Musallam A, Xia Z, Baruch N, Messina S, Healy BC, Chitnis T. Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity. Mult Scler Relat Disord. 2016 Jul; 8:136-40. PMID: 27456889.
    Citations: 13     Fields:    Translation:Humans
  123. Khalid F, Tauhid S, Chua AS, Healy BC, Stankiewicz JM, Weiner HL, Bakshi R. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis. Int J Neurosci. 2017 May; 127(5):396-403. PMID: 27143245.
    Citations: 3     Fields:    Translation:Humans
  124. Huffman JC, Boehm JK, Beach SR, Beale EE, DuBois CM, Healy BC. Relationship of optimism and suicidal ideation in three groups of patients at varying levels of suicide risk. J Psychiatr Res. 2016 Jun; 77:76-84. PMID: 26994340.
    Citations: 5     Fields:    Translation:Humans
  125. Laíns I, Bartosch C, Mondim V, Healy B, Kim IK, Husain D, Miller JW. Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis. Am J Ophthalmol. 2016 05; 165:54-64. PMID: 26940164.
    Citations: 10     Fields:    Translation:Humans
  126. Cavallari M, Palotai M, Glanz BI, Egorova S, Prieto JC, Healy BC, Chitnis T, Guttmann CR. Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients. Mult Scler. 2016 12; 22(14):1841-1849. PMID: 26920374.
    Citations: 9     Fields:    Translation:Humans
  127. Celano CM, Healy B, Suarez L, Levy DE, Mastromauro C, Januzzi JL, Huffman JC. Cost-Effectiveness of a Collaborative Care Depression and Anxiety Treatment Program in Patients with Acute Cardiac Illness. Value Health. 2016 Mar-Apr; 19(2):185-91. PMID: 27021752.
    Citations: 12     Fields:    Translation:Humans
  128. Kim G, Tauhid S, Dupuy SL, Tummala S, Khalid F, Healy BC, Bakshi R. An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis. J Neurol. 2016 Mar; 263(3):531-8. PMID: 26754005; PMCID: PMC4785194.
    Citations: 4     Fields:    Translation:Humans
  129. Rotstein DL, Healy BC, Malik MT, Carruthers RL, Musallam AJ, Kivisakk P, Weiner HL, Glanz B, Chitnis T. Effect of vitamin D on MS activity by disease-modifying therapy class. Neurol Neuroimmunol Neuroinflamm. 2015 Dec; 2(6):e167. PMID: 26568968.
    Citations: 18     Fields:    
  130. Oommen VV, Tauhid S, Healy BC, Chua AS, Malik MT, Diaz-Cruz C, Dupuy SL, Weiner HL, Chitnis T, Bakshi R. The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis. J Neuroimaging. 2016 Mar-Apr; 26(2):184-7. PMID: 26445919.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  131. Bove R, Healy BC, Musallam A, Glanz BI, De Jager PL, Chitnis T. Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort. Mult Scler. 2016 06; 22(7):935-43. PMID: 26447063; PMCID: PMC4824677.
    Citations: 15     Fields:    Translation:Humans
  132. Chua AS, Glanz BI, Guarino AJ, Cook SL, Greeke EE, Little GE, Chitnis T, Healy BC. Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure. Mult Scler Relat Disord. 2015 Nov; 4(6):598-606. PMID: 26590669.
    Citations: 2     Fields:    Translation:Humans